DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Nitz U.
Prospective WSG Phase III PlanB trial: Clinical outcome at 5-year follow up and impact of 21 Gene Recurrence Score result, central/localpathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer. Vortrag ESMO/ECCO-Jahrestagung 2016, LBA 8.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.